Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Rapid Medical Research, Inc.
130
mi
from 43215
Cleveland, OH
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Rapid Medical Research, Inc.
130
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
PEAK Research LLC
157
mi
from 43215
Upper St. Clair, PA
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
PEAK Research LLC
157
mi
from 43215
Upper St. Clair, PA
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Coastal Medical
615
mi
from 43215
East Greenwich, RI
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Coastal Medical
615
mi
from 43215
East Greenwich, RI
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Omega Medical Research
615
mi
from 43215
Warwick, RI
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Omega Medical Research
615
mi
from 43215
Warwick, RI
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Coastal Carolina Research Center
523
mi
from 43215
Mt. Pleasant, SC
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Coastal Carolina Research Center
523
mi
from 43215
Mt. Pleasant, SC
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Meridian Clinical Research
720
mi
from 43215
Dakota Dunes, SD
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Meridian Clinical Research
720
mi
from 43215
Dakota Dunes, SD
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Clinical Research Associates
333
mi
from 43215
Nashville, TN
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Clinical Research Associates
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Research Across America
907
mi
from 43215
Dallas, TX
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Research Across America
907
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Texas Center for Drug Development, P.A.
991
mi
from 43215
Houston, TX
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Texas Center for Drug Development, P.A.
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Research Across America
1008
mi
from 43215
Katy, TX
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Research Across America
1008
mi
from 43215
Katy, TX
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Advanced Clinical Research, Inc.
1519
mi
from 43215
West Jordan, UT
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Advanced Clinical Research, Inc.
1519
mi
from 43215
West Jordan, UT
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated:  1/26/2016
Dr. Calvin Powell Professional Medical Corporation
1562
mi
from 43215
Bay Roberts,
A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.
A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years
Status: Enrolling
Updated: 1/26/2016
Dr. Calvin Powell Professional Medical Corporation
1562
mi
from 43215
Bay Roberts,
Click here to add this to my saved trials
A Comparative Study to Evaluate Two Air-Activated Adhesive Backed Heat Patches
A Randomized, Open-Label, Comparative Study To Evaluate the Adhesion and Temperature Properties of Two Air-Activated, Adhesive Backed Heat Patches in Healthy Volunteers
Status: Enrolling
Updated:  1/26/2016
Radiant Research
1653
mi
from 43215
Chandler, AZ
A Comparative Study to Evaluate Two Air-Activated Adhesive Backed Heat Patches
A Randomized, Open-Label, Comparative Study To Evaluate the Adhesion and Temperature Properties of Two Air-Activated, Adhesive Backed Heat Patches in Healthy Volunteers
Status: Enrolling
Updated: 1/26/2016
Radiant Research
1653
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Anti-platelet Effects of Colchicine in Healthy Volunteers
Anti-platelet Effects of Colchicine in Healthy Volunteers
Status: Enrolling
Updated:  1/26/2016
New York University School of Medicine
479
mi
from 43215
New York, NY
Anti-platelet Effects of Colchicine in Healthy Volunteers
Anti-platelet Effects of Colchicine in Healthy Volunteers
Status: Enrolling
Updated: 1/26/2016
New York University School of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
The Use of Music Therapy in the Prevention of Falls
Posturographic Changes Associated With Music Therapy and Fall Prevention
Status: Enrolling
Updated:  1/26/2016
Carrick Institute for Graduate Studies
811
mi
from 43215
Cape Canaveral, FL
The Use of Music Therapy in the Prevention of Falls
Posturographic Changes Associated With Music Therapy and Fall Prevention
Status: Enrolling
Updated: 1/26/2016
Carrick Institute for Graduate Studies
811
mi
from 43215
Cape Canaveral, FL
Click here to add this to my saved trials
Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)
A Randomized, Open-Label Study to Evaluate the Temperature Profile and Adhesion of an Air-Activated Adhesive-Backed Heat Patch in Healthy Volunteers
Status: Enrolling
Updated:  1/26/2016
Wilkins Research
359
mi
from 43215
Chattanooga, TN
Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)
A Randomized, Open-Label Study to Evaluate the Temperature Profile and Adhesion of an Air-Activated Adhesive-Backed Heat Patch in Healthy Volunteers
Status: Enrolling
Updated: 1/26/2016
Wilkins Research
359
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
Migraine and Body Composition
Migraine and Body Composition
Status: Enrolling
Updated:  1/27/2016
The Johns Hopkins Bayview Headache Center
344
mi
from 43215
Baltimore, MD
Migraine and Body Composition
Migraine and Body Composition
Status: Enrolling
Updated: 1/27/2016
The Johns Hopkins Bayview Headache Center
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Comparison of Tenofovir Vaginal Gel and Film Formulations
Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Tenofovir Vaginal Gel and Film Formulation
Status: Enrolling
Updated:  1/27/2016
The Johns Hopkins University School of Medicine Division of Clinical Pharmacology
342
mi
from 43215
Baltimore, MD
Comparison of Tenofovir Vaginal Gel and Film Formulations
Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Tenofovir Vaginal Gel and Film Formulation
Status: Enrolling
Updated: 1/27/2016
The Johns Hopkins University School of Medicine Division of Clinical Pharmacology
342
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
An Interaction Study to Assess Drug Levels in Healthy Adult Subjects
Steady State Pharmacokinetics (PK) of Fosamprenavir (FPV) Alone or in Combination With Low Dose Ritonavir (/r) (1400mg BID, 1400mg/100mg QD or 700/100mg BID) and the Chemokine Receptor 5 (CCR5) Entry Inhibitor Maraviroc (MVC) 300mg BID in Healthy Volunteers
Status: Enrolling
Updated:  1/27/2016
Garden State Infectious Disease Associates, PA
427
mi
from 43215
Voorhees, NJ
An Interaction Study to Assess Drug Levels in Healthy Adult Subjects
Steady State Pharmacokinetics (PK) of Fosamprenavir (FPV) Alone or in Combination With Low Dose Ritonavir (/r) (1400mg BID, 1400mg/100mg QD or 700/100mg BID) and the Chemokine Receptor 5 (CCR5) Entry Inhibitor Maraviroc (MVC) 300mg BID in Healthy Volunteers
Status: Enrolling
Updated: 1/27/2016
Garden State Infectious Disease Associates, PA
427
mi
from 43215
Voorhees, NJ
Click here to add this to my saved trials
An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects
A Randomized, Open-Label, Six-Period, Drug Interaction Study to Assess Steady-State Plasma Amprenavir (APV) and Raltegravir (RTG) Pharmacokinetics Following Administration of RTG 400 mg BID for 14 Days Alone and in Combination With 14 Days of Either Fosamprenavir (FPV) 1400 mg BID, FPV 700 mg BID + RTV 100 mg BID or FPV 1400 mg + RTV 100 mg QD in Healthy Adult Subjects When Under Fasting Conditions
Status: Enrolling
Updated:  1/27/2016
Garden State Infectious Disease Associates, PA
427
mi
from 43215
Voorhees, NJ
An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects
A Randomized, Open-Label, Six-Period, Drug Interaction Study to Assess Steady-State Plasma Amprenavir (APV) and Raltegravir (RTG) Pharmacokinetics Following Administration of RTG 400 mg BID for 14 Days Alone and in Combination With 14 Days of Either Fosamprenavir (FPV) 1400 mg BID, FPV 700 mg BID + RTV 100 mg BID or FPV 1400 mg + RTV 100 mg QD in Healthy Adult Subjects When Under Fasting Conditions
Status: Enrolling
Updated: 1/27/2016
Garden State Infectious Disease Associates, PA
427
mi
from 43215
Voorhees, NJ
Click here to add this to my saved trials
CBT for Social Anxiety Disorder Delivered by School Counselors
CBT for Social Anxiety Disorder Delivered by School Counselors
Status: Enrolling
Updated:  1/28/2016
New York University School of Medicine
479
mi
from 43215
New York, NY
CBT for Social Anxiety Disorder Delivered by School Counselors
CBT for Social Anxiety Disorder Delivered by School Counselors
Status: Enrolling
Updated: 1/28/2016
New York University School of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Lung HIV Microbiome Project (Michigan Site)
Understanding the Lung Microbiome in HIV-Infected & HIV-Uninfected Individuals
Status: Enrolling
Updated:  1/28/2016
VA Ann Arbor Healthcare System
163
mi
from 43215
Ann Arbor, MI
Lung HIV Microbiome Project (Michigan Site)
Understanding the Lung Microbiome in HIV-Infected & HIV-Uninfected Individuals
Status: Enrolling
Updated: 1/28/2016
VA Ann Arbor Healthcare System
163
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Recovery and Survival of EryDex in Non-patient Volunteers
Determination of the in Vivo Recovery and Survival of EryDex (Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes) in Non-patient Volunteers
Status: Enrolling
Updated:  1/29/2016
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Recovery and Survival of EryDex in Non-patient Volunteers
Determination of the in Vivo Recovery and Survival of EryDex (Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes) in Non-patient Volunteers
Status: Enrolling
Updated: 1/29/2016
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Drug-Drug Interaction Study in Healthy Adult Volunteers
Status: Enrolling
Updated:  1/29/2016
PPD
1068
mi
from 43215
Austin, TX
Drug-Drug Interaction Study in Healthy Adult Volunteers
Status: Enrolling
Updated: 1/29/2016
PPD
1068
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Use of Specially Designed Pediatric MR Coils on Clinical Scanners
Novel Coils for Pediatric Musculoskeletal MRI
Status: Enrolling
Updated:  2/1/2016
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Use of Specially Designed Pediatric MR Coils on Clinical Scanners
Novel Coils for Pediatric Musculoskeletal MRI
Status: Enrolling
Updated: 2/1/2016
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
The Effect of Heat on Blood and Oxygen Flow Readings Part 2
The Effect of Heat on Blood and Oxygen Flow Readings Part 2
Status: Enrolling
Updated:  2/1/2016
VA Pittsburgh Healthcare System
161
mi
from 43215
Pittsburgh, PA
The Effect of Heat on Blood and Oxygen Flow Readings Part 2
The Effect of Heat on Blood and Oxygen Flow Readings Part 2
Status: Enrolling
Updated: 2/1/2016
VA Pittsburgh Healthcare System
161
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated:  2/1/2016
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated: 2/1/2016
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated:  2/1/2016
Rockefeller University
477
mi
from 43215
New York, NY
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated: 2/1/2016
Rockefeller University
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated:  2/1/2016
Weill Cornell Medical Center
479
mi
from 43215
New York, NY
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated: 2/1/2016
Weill Cornell Medical Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated:  2/1/2016
University of Cologne
4149
mi
from 43215
Cologne,
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Status: Enrolling
Updated: 2/1/2016
University of Cologne
4149
mi
from 43215
Cologne,
Click here to add this to my saved trials
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Lpathomab Administered Intravenously to Healthy Volunteers
Status: Enrolling
Updated:  2/1/2016
PRA Health Sciences
1512
mi
from 43215
Salt Lake City, UT
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Lpathomab Administered Intravenously to Healthy Volunteers
Status: Enrolling
Updated: 2/1/2016
PRA Health Sciences
1512
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
A Double-blind, Randomized, Placebo-controlled, Crossover Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
Status: Enrolling
Updated:  2/1/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
A Double-blind, Randomized, Placebo-controlled, Crossover Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
Status: Enrolling
Updated: 2/1/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Status: Enrolling
Updated:  2/1/2016
Emory University
435
mi
from 43215
Atlanta, GA
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Status: Enrolling
Updated: 2/1/2016
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Status: Enrolling
Updated:  2/1/2016
Adolescent and Young Adult Center (AYAC),UMB
344
mi
from 43215
Baltimore, MD
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Status: Enrolling
Updated: 2/1/2016
Adolescent and Young Adult Center (AYAC),UMB
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Status: Enrolling
Updated:  2/1/2016
Center for Vaccine Development, University of Maryland
344
mi
from 43215
Baltimore, MD
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
Status: Enrolling
Updated: 2/1/2016
Center for Vaccine Development, University of Maryland
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
A Phase I, Single Center, Open Label, Randomized, Single-Dose, Five-Way Crossover Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® in Healthy Volunteers
Status: Enrolling
Updated:  2/2/2016
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
A Phase I, Single Center, Open Label, Randomized, Single-Dose, Five-Way Crossover Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® in Healthy Volunteers
Status: Enrolling
Updated: 2/2/2016
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population
Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population
Status: Enrolling
Updated:  2/3/2016
MeYou Health
644
mi
from 43215
Boston, MA
Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population
Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population
Status: Enrolling
Updated: 2/3/2016
MeYou Health
644
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Blood Neurotrophic Factors in Adults
Blood Neurotrophic Factors in Adults
Status: Enrolling
Updated:  2/4/2016
Posit Science Corporation
2106
mi
from 43215
San Francisco, CA
Blood Neurotrophic Factors in Adults
Blood Neurotrophic Factors in Adults
Status: Enrolling
Updated: 2/4/2016
Posit Science Corporation
2106
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
A New Adaptive Physical Activity Technology in Older Adults
A New Adaptive Physical Activity Technology in Older Adults (Jintronix)
Status: Enrolling
Updated:  2/4/2016
Oak Hammock at University of Florida
713
mi
from 43215
Gainesville, FL
A New Adaptive Physical Activity Technology in Older Adults
A New Adaptive Physical Activity Technology in Older Adults (Jintronix)
Status: Enrolling
Updated: 2/4/2016
Oak Hammock at University of Florida
713
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
The Role of Mid-Life Adiposity in Functional Brain Connectivity
The Role of Mid-Life Adiposity in Functional Brain Connectivity
Status: Enrolling
Updated:  2/8/2016
Medical College of Wisconsin/ Froedtert Hospital
335
mi
from 43215
Milwaukee, WI
The Role of Mid-Life Adiposity in Functional Brain Connectivity
The Role of Mid-Life Adiposity in Functional Brain Connectivity
Status: Enrolling
Updated: 2/8/2016
Medical College of Wisconsin/ Froedtert Hospital
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Phase 1 Study of NPT200-11 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Single Ascending Dose Trial of the Safety, Tolerability and Pharmacokinetics of NPT200-11 in Healthy Subjects
Status: Enrolling
Updated:  2/12/2016
Celerion
1657
mi
from 43215
Tempe, AZ
Phase 1 Study of NPT200-11 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Single Ascending Dose Trial of the Safety, Tolerability and Pharmacokinetics of NPT200-11 in Healthy Subjects
Status: Enrolling
Updated: 2/12/2016
Celerion
1657
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
A Novel Neurorehabilitation Approach for Cognitive Aging With HIV
Speed of Processing Training With Transcranial Direct Current Stimulation in Older HIV+ Adults (HtDCS)
Status: Enrolling
Updated:  2/14/2016
UAB 1917 Clinic
493
mi
from 43215
Birmingham, AL
A Novel Neurorehabilitation Approach for Cognitive Aging With HIV
Speed of Processing Training With Transcranial Direct Current Stimulation in Older HIV+ Adults (HtDCS)
Status: Enrolling
Updated: 2/14/2016
UAB 1917 Clinic
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
Women In Steady Exercise Research (WISER) Sister
Status: Enrolling
Updated:  2/17/2016
Abramson Cancer Center of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
Women In Steady Exercise Research (WISER) Sister
Status: Enrolling
Updated: 2/17/2016
Abramson Cancer Center of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Status: Enrolling
Updated:  2/18/2016
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Status: Enrolling
Updated: 2/18/2016
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Status: Enrolling
Updated:  2/18/2016
UW Health Oncology - 1 South Park
392
mi
from 43215
Madison, WI
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Status: Enrolling
Updated: 2/18/2016
UW Health Oncology - 1 South Park
392
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Metabolic Effects of Androgenicity in Aging Men and Women
Metabolic Effects of Androgenicity in Aging Men and Women
Status: Enrolling
Updated:  2/19/2016
VA Greater Los Angeles Healthcare System, West LA
1982
mi
from 43215
West Los Angeles, CA
Metabolic Effects of Androgenicity in Aging Men and Women
Metabolic Effects of Androgenicity in Aging Men and Women
Status: Enrolling
Updated: 2/19/2016
VA Greater Los Angeles Healthcare System, West LA
1982
mi
from 43215
West Los Angeles, CA
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
Kosair Children's Hospital
187
mi
from 43215
Louisville, KY
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Kosair Children's Hospital
187
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
University of California San Francisco Medical Center-Parnassus
1982
mi
from 43215
San Francisco, CA
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
University of California San Francisco Medical Center-Parnassus
1982
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
Children's Hospital Colorado
1153
mi
from 43215
Aurora, CO
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Children's Hospital Colorado
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials